acebutolol

(redirected from Monitan)
Also found in: Dictionary, Thesaurus.
Related to Monitan: acebutolol

acebutolol

 [as″ĕ-bu´to-lol]
a cardioselective β1-adrenergic blocking agent with intrinsic sympathomimetic activity; used in the form of the hydrochloride salt for treatment of hypertension, angina pectoris, and arrhythmias; administered orally.

acebutolol

/ac·e·bu·to·lol/ (as″ĕ-bu´tah-lol) a cardioselective β1-adrenergic blocking agent with intrinsic sympathomimetic activity; used as the hydrochloride salt in the treatment of hypertension, anginia pectoris, and arrhythmias.

acebutolol

(ăs′ə-byo͞o′tə-lôl′, -lōl′)
n.
A beta-blocker drug, C18H28N2O4, used in its hydrochloride form to treat hypertension and certain cardiac arrhythmias.

acebutolol

[as′əbo̅o̅′təlol]
an antiadrenergic agent.
indications It is prescribed in the treatment of hypertension, angina pectoris, ventricular arrhythmias, and other cardiovascular disorders.
contraindications The drug should not be given to patients with asthma, persistent severe bradycardia, second- and third-degree heart block, overt heart failure, cardiogenic shock, and peripheral vascular disease. It is generally not recommended during pregnancy.
adverse effects The most common side effects include fatigue, bradycardia, bronchospasm, flatulence, hypotension, muscle and joint pains, nausea, constipation, diarrhea, headache, rash, dizziness, and insomnia.

Acebutolol

A cardioselective beta-1-blocker for managing hypertension and tachyarrhythmias.
Adverse effects Antinuclear antibodies (in ±30%), arthralgia, myalgia, skin rash

acebutolol

Sectral® Cardiology A β1-blocker for managing HTN and tachydysrhythmias, effective in most other clinical uses of beta blockers Adverse effects Antinuclear antibodies; SLE-like disease is rare. See β-blocker.

acebutolol

A beta-blocker drug commonly used to treat high blood pressure (HYPERTENSION), ANGINA PECTORIS, heart failure and heart irregularities (arrhythmias). A brand name is Sectral. Formulated with HYDROCHLOROTHIAZIDE it is marketed as Secadrex.